These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6339367)

  • 1. The human immune response region (HLA-D) and disease susceptibility.
    Stastny P; Ball EJ; Dry PJ; Nunez G
    Immunol Rev; 1983; 70():113-53. PubMed ID: 6339367
    [No Abstract]   [Full Text] [Related]  

  • 2. [The HLA histocompatibility system].
    Wadgymar A
    Rev Invest Clin; 1984; 36(3):287-92. PubMed ID: 6393263
    [No Abstract]   [Full Text] [Related]  

  • 3. Heterogeneity of autoimmune thyroiditis.
    Bech K; Bliddal H; Feldt-Rasmussen U; Kappelgaard E; Nielsen H
    Allergy; 1984 May; 39(4):239-47. PubMed ID: 6375440
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune response to autologous human melanoma: implication of class I and II MHC products.
    Fossati G; Anichini A; Taramelli D; Balsari A; Gambacorti-Passerini C; Kirkwood JM; Parmiani G
    Biochim Biophys Acta; 1986 Dec; 865(3):235-51. PubMed ID: 3539196
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental autoimmune nephropathies: induction and regulation.
    Druet P; Glotz D
    Adv Nephrol Necker Hosp; 1984; 13():115-33. PubMed ID: 6206693
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic regulation of the immune response in man.
    Matej H
    Acta Anthropogenet; 1985; 9(1-3):20-30. PubMed ID: 3939669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-linked genes controlling immune response and disease susceptibility.
    Sasazuki T; Nishimura Y; Muto M; Ohta N
    Immunol Rev; 1983; 70():51-75. PubMed ID: 6403457
    [No Abstract]   [Full Text] [Related]  

  • 8. Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium.
    Pober JS; Collins T; Gimbrone MA; Libby P; Reiss CS
    Transplantation; 1986 Feb; 41(2):141-6. PubMed ID: 2935977
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression of class II major histocompatibility antigens on reactive astrocytes and endothelial cells within the gliosis surrounding metastases and abscesses.
    Frank E; Pulver M; de Tribolet N
    J Neuroimmunol; 1986 Jul; 12(1):29-36. PubMed ID: 3458714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity.
    Hanafusa T; Pujol-Borrell R; Chiovato L; Russell RC; Doniach D; Bottazzo GF
    Lancet; 1983 Nov; 2(8359):1111-5. PubMed ID: 6138646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New concepts of glomerular injury.
    Fillit HM; Zabriskie JB
    Lab Invest; 1984 Aug; 51(2):117-20. PubMed ID: 6205218
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunomodulatory effects of interferons on human mononuclear cells with special reference to the expression of cell surface antigens.
    Hokland ME
    Acta Pathol Microbiol Immunol Scand Suppl; 1985; 286():1-35. PubMed ID: 2408439
    [No Abstract]   [Full Text] [Related]  

  • 13. Murine monoclonal antibodies and human alloantisera specific for HLA inhibit monocyte phagocytosis of anti-D-sensitized human red blood cells.
    Neppert J; Marquard F; Mueller-Eckhardt C
    Eur J Immunol; 1985 Jun; 15(6):559-63. PubMed ID: 3924629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DR antigens on lymphoid cells differ from those on myeloid cells.
    Torok-Storb B; Nepom GT; Nepom BS; Hansen JA
    Nature; 1983 Oct 6-12; 305(5934):541-3. PubMed ID: 6194439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA, immune response and disease.
    Mehra NK; Taneja V
    Indian J Pediatr; 1989; 56(2):171-9. PubMed ID: 2509344
    [No Abstract]   [Full Text] [Related]  

  • 16. Monocyte and endothelial antigens.
    Stastny P; Nunez G
    Prog Clin Biol Res; 1983; 133():15-22. PubMed ID: 6353417
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell-mediated cytotoxicity against HLA-D-region products expressed in monocytes and B lymphocytes. IV. Characterization of effector cells using monoclonal antibodies against human T-cell subsets.
    Ball EJ; Stastny P
    Immunogenetics; 1982; 16(2):157-69. PubMed ID: 6216209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization and characterization of major histocompatibility complex class II-positive cells in the posterior segment of the eye: implications for induction of autoimmune uveoretinitis.
    Forrester JV; McMenamin PG; Holthouse I; Lumsden L; Liversidge J
    Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):64-77. PubMed ID: 8300365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-A, B, C; -DR; -MT, -MB, and SB antigens on unstimulated human endothelial cells.
    Neppert J; Nunez G; Stastny P
    Tissue Antigens; 1984 Jul; 24(1):40-7. PubMed ID: 6592794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of anti-class I cytotoxicity by anti-class II monoclonal antibodies (MoAb). II. Blocking of anti-class I CTL clones by anti-DR MoAb.
    Anichini A; Ress S; Strassmann G; Bach FH
    Hum Immunol; 1985 Jun; 13(2):139-43. PubMed ID: 2409062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.